SHAREHOLDERS' EQUITY |
6 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Equity [Abstract] | |
| SHAREHOLDERS' EQUITY | 8. SHAREHOLDERS’ EQUITY Dividend Reinvestment Plan In March 2024, we implemented the Watsco, Inc. Dividend Reinvestment Plan (the “DRIP”), under which existing shareholders may, in accordance with the DRIP, acquire up to an aggregate of 300,000 shares of each of Common and Class B common stock, as applicable, by reinvesting all or a portion of the cash dividends paid on such shareholders’ shares of common stock. The DRIP has been registered under the Securities Act of 1933, as amended (the “Securities Act”), pursuant to our automatically effective shelf registration statement on Form S-3 (File No. 333-282975). During the quarters ended June 30, 2026 and 2025, 9,456 and 16,553 shares of our common stock, respectively, were issued under the DRIP. During the six months ended June 30, 2026 and 2025, 19,346 and 30,495 shares of our common stock, respectively, were issued under the DRIP. At-the-Market Offering Program In May 2024, we entered into an amended and restated sales agreement with Robert W. Baird & Co. Inc. (the “2024 ATM Program”), which enables the issuance and sale of Common stock for a maximum aggregate offering amount of up to $400,000. At June 30, 2026, $400,000 was available for sale under the 2024 ATM Program. The offer and sale of shares under the 2024 ATM Program have been registered under the Securities Act pursuant to our automatically effective shelf registration statement on Form S-3 (File No. 333-282975). Common Stock Dividends We paid cash dividends of $3.30, $3.00, $6.30, and $5.70 per share on common stock during the quarters and six months ended June 30, 2026 and 2025, respectively. Restricted Stock During the quarter and six months ended June 30, 2026, a total of 2,206 shares of common stock with an aggregate fair market value of $813, and a total of 3,637 shares of commons stock with an aggregate fair market value of $1,377, respectively, were withheld as payment in lieu of cash to satisfy tax withholding obligations in connection with the vesting of restricted stock. These shares were retired upon delivery. Exercise of Stock Options Cash received from Common stock issued upon the exercise of stock options during the quarters and six months ended June 30, 2026 and 2025 was $7,880, $2,462, $12,994, and $12,860, respectively. During the six months ended June 30, 2026, 589 shares of Common stock with an aggregate fair market value of $242 were withheld as payment in lieu of cash for stock option exercises and related tax withholdings. These shares were retired upon delivery. During the quarter and six months ended June 30, 2025, 2,232 shares of Common stock with an aggregate fair market value of $1,067 were withheld as payment in lieu of cash for stock option exercises and related tax withholdings. These shares were retired upon delivery. Employee Stock Purchase Plan During the quarters ended June 30, 2026 and 2025, we received proceeds of $612 and $582, respectively, for shares of our Common stock purchased under our employee stock purchase plan. During the six months ended June 30, 2026 and 2025, we received proceeds of $1,260 and $1,233, respectively, for shares of our Common stock purchased under our employee stock purchase plan. |